SEP 20, 2018 05:00 PM PDT

Chemotherapeutic Drugs Battle Antimalarial Drug Resistance

WRITTEN BY: Nouran Amin

Credit: Hindustan Times

According to the latest research published in the journal Nature Communications, researchers discovered that chemotherapeutic drugs can increase the effectiveness of the most powerful antimalarial drug: artemisinin.

In the battle against drug resistance and treating malaria, artemisinin was discovered to work through a "double whammy" attack on the deadly parasite responsible for malaria—thanks to researchers from the University of Melbourne and the Japanese pharmaceutical company Takeda.

Artemisinin works by damaging the proteins present in malaria parasites eventually clogging the parasite's waste disposal system: the proteasome. Resistance to artemisinin has developed in South-East Asia and it may reach Africa soon. Understanding the workings of artemisinin is crucial in fighting malaria, which claims the life of about 450,000 people annually.

Watch this short video about the anti-malarial drug, Artemisinin:

"The double whammy effect means that combining artemisinin with an anti-cancer drug that also targets the proteasome, complements the activity of artemisinin, and can restore activity against artemisinin-resistant parasites,” explains Professor Leann Tilley of the University of Melbourne. "The parasite's proteasome is like a shredder that chews up damaged or used-up proteins. Treating malaria parasites with artemisinin generates a lot of damaged proteins. Artemisinin and proteasome inhibitors thus can work together to jam the recycling system."

The clogging of the proteasome leads to protein accumulation marked as the “kiss of death” as these proteins eventually stress the parasite and causing cell death. Thus, the collaboration between University of Melbourne researchers and Takeda was to identify parasite-specific proteasome inhibitors in order to develop drugs needed to advance to clinical studies.” At Takeda, we are proud to contribute our expertise to help address critical global health problems. In this case, we were able to leverage our oncology research on the proteasome system and uncover a potential new way to treat malaria," explains Larry Dick, Director at Takeda.

"Electron microscope images of malaria parasites (blue )and chemical structure of artemisinin." Image Credit: Dr Eric Hanssen, University of Melbourne via Science Daily

"We are currently undertaking medicinal chemistry work to create novel analogs of human proteasome inhibitors that specifically inhibit the parasite proteasome,” Professor Tilley said. "We want a compound that can be administered orally and will last a long time in the bloodstream. If a suitable compound can be found, human trials could happen very soon."

Source: University of Melbourne, Nature Communications

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Sickle cell drug promising in clinical trial
UConn School of Medicine researchers report that an investigational drug used for treating for the sickle cell disease has shown promising results in early...
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
New Drug Target for Chemically-Induced Parkinson Disease
Once upon a time, a compound found in synthetic opioid, MPTP induced the onset of Parkinson's disease. Early studies show that MPTP induces Parkinson d...
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Blood Pressure Medication May Increase Risk for Bowel Condition
According to early-stage research, calcium-channel blocker, which is certain type of a blood pressure lowering drug, may increase the risk of a bowel condi...
SEP 20, 2019
Microbiology
SEP 20, 2019
Picturing a New Kind of Antibiotic
Scientists have deciphered the X-ray crystal structure of an enzyme that generates a unique broad spectrum antibiotic called obafluorin....
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Can FDA Approved Ketamine Drug Spravato Really Treat Depression?
President Trump is allegedly in support of a new drug to combat depression. He even urged the Department of Veterans Affairs to purchase it and “get ...
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Adderall is Almost Identical to Crystal Meth
Adderall has a reputation for giving people a feeling of euphoria, increasing energy levels and enhancing abilities to focus and concentrate. And coinciden...
Loading Comments...